Business Context and Reporting Period
This Form 8-K is filed by Neuralstem, Inc. (not Palisade Bio, Inc.) for the event date of October 12, 2011. The report discloses a regulatory milestone regarding intellectual property rather than financial results.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a patent allowance and contains no financial statements.
Material Changes
There are no financial changes reported. The material event is the receipt of a notice of allowance from the U.S. Patent and Trademark Office for patent application 12/418,170, titled "Spinal Platform and Method for Delivering a Therapeutic Agent to a Spinal Cord Target."
Guidance, Outlook, and Risks
The filing does not contain financial guidance, management commentary on future performance, or specific risk factors. It includes a standard disclaimer stating that the information is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Verify the company name is Neuralstem, Inc., as the input metadata incorrectly listed Palisade Bio, Inc.
- Confirm the status of patent application 12/418,170 with the U.S. Patent and Trademark Office.
- Review the attached press release (Exhibit 99.01) for details on the commercial potential of the spinal platform.
- Check subsequent filings for any financial impact or licensing agreements related to this patent.